Regioselective Glycosylation of Fluorine-18-Labeled Sorbitol for Enhanced Bacterial Detection In Vivo Using PET
Precise and rapid detection of bacterial infection in vivo remains a significant challenge in clinical practice. In response to this challenge, several pathogen-specific positron emission tomography (PET) tracers have been developed, including the fluorine-18-labeled sorbitol derivative [<sup>18</sup>F]-FDS, which shows great promise in detecting bacterial infections in patients. In this study, we tested the hypothesis that the diagnostic performance of [<sup>18</sup>F]-FDS could be modulated via regioselective glycosylation to improve radiotracer stability, broaden organism sensitivity, and tune pharmacodynamics. A synthetic sequence was developed, whereby the common radiotracer [<sup>18</sup>F]-FDG was converted chemoenzymatically to α- and β-linked disaccharides via reverse phosphorolysis and subsequently reduced to the corresponding glycosylated [<sup>18</sup>F]-FDS derivatives. This strategy allowed the syntheses of glucopyranosyl-d-sorbitol analogs [<sup>18</sup>F]-FNT (α-1,3 linked), [<sup>18</sup>F]-FMT (α-1,4 linked), [<sup>18</sup>F]-FLT (β-1,3 linked), and [<sup>18</sup>F]-FCT (β-1,4 linked). Among these tracers, the α-linked analogs [<sup>18</sup>F]-FNT and [<sup>18</sup>F]-FMT showed greater uptake in both Gram-positive and Gram-negative pathogens compared to the β-linked analogs [<sup>18</sup>F]-FLT and [<sup>18</sup>F]-FCT. In vivo time-course PET imaging of [<sup>18</sup>F]-FNT and [<sup>18</sup>F]-FMT in uninfected mice revealed favorable pharmacokinetics, including rapid urinary excretion, minimal hepatobiliary retention, and low off-target signals. PET imaging using [<sup>18</sup>F]-FNT and [<sup>18</sup>F]-FMT detected <i>Klebsiella pneumoniae</i> pulmonary infections in mice with high infected/uninfected tissue ratios (∼6-fold). [<sup>18</sup>F]-FNT also showed high infected/uninfected tissue ratios (∼28-fold) in <i>Staphylococcus aureus</i> myositis, whereas the parent [<sup>18</sup>F]-FDS tracer was not taken up by the Gram-positive organisms tested. Our findings highlight the potential for PET tracer glycosylation as a tool to modulate target specificity and improve imaging sensitivity. These results also establish [<sup>18</sup>F]-FNT as a highly promising PET tracer with a high translational potential for detecting bacterial infection in vivo.
Authors
- Joanne N. Engel (ORCID: https://orcid.org/0000-0002-2168-9711)
- Joseph E. Blecha
- David M. Wilson (ORCID: https://orcid.org/0000-0002-1095-046X)
- Marina López‐Álvarez (ORCID: https://orcid.org/0000-0001-5794-5951)
- Michael A. Ohliger (ORCID: https://orcid.org/0000-0001-6878-8189)
- Alexandre M. Sorlin (ORCID: https://orcid.org/0000-0002-9589-6131)
- Mohammad Yaqoob Bhat (ORCID: https://orcid.org/0000-0002-0888-5603)
- Youngho Seo (ORCID: https://orcid.org/0000-0001-5908-6636)
- Robert R. Flavell (ORCID: https://orcid.org/0000-0002-8694-1199)
- Jung Min Kim (ORCID: https://orcid.org/0009-0003-9492-510X)
- Sang‐Hee Lee (ORCID: https://orcid.org/0000-0001-8578-9968)
Institutions
- San Francisco General Hospital (US)
- University of California, San Francisco (US)
Publication Details
- Journal
- JACS Au
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1021/jacsau.5c01153
- Citations
- 1
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01